4-Dimethylaminoazobenzene-4-carboxylic Acid

4-Dimethylaminoazobenzene-4-carboxylic Acid

Catalog Number:
FC01229712BIO
Mfr. No.:
FD76930
Price:
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Dabcyl acid 4-dimethylaminobenzene-4’-carboxylic acid is a dark quencher chromophore that absorbs in the visible region and serves as an acceptor in FRET applications. It is widely used to measure protease activity by labelling a suitable peptide substrate with a fluorophore donor and a dabcyl dark quencher as an acceptor. The fluorophore-quencher energy transfer is related to distance (normally within 10nm). The peptide is cleaved by the protease action and the dabcyl quencher diffuses away from the fluorophore, and the fluorescence is measured. In RT-PCR, it is used at the non-fluorescent 3’ terminal of oligonucleotides as a quencher.

          Please contact us at for specific academic pricing.

      • Properties
        • Categories
          Fine Chemicals
          Alternative Name
          Dabcyl acid
          CAS Number
          6268-49-1
          Molecular Formula
          C15H15N3O2
          Molecular Weight
          269.3 g/mol
          MDL Number
          MFCD00058988
          Note
          There is no hazardous surcharge associated with this product.
          There is no special packaging charge associated with this product.

          * For research use only. Not for human or veterinary use

      • Reference
        • Chen., et al. (2005). Enzymatic activity characterization of SARS coronavirus 3C-likeprotease by fluorescence resonance energy transfer technique. Actapharmacologica Sinica 26: 99–106
          Kovaliov., et al. (2014). Synthesis and evaluation of a photoresponsive quencher forfluorescent hybridization probes. Organic & biomolecular chemistry 12:7844-7858
          Shang., et al. (2015). Biochemical Characterization of Recombinant Enterovirus 71 3C Protease with Fluorogenic Model Peptide Substrates and Development of a Biochemical Assay. Antimicrobial Agent Chemotherapy 59(4): 1827–1836.

    Documents

    Specification

    Note: If you don't receive our verification email, do the following:

    • Confirm that you entered your email address correctly.
    • Check if the email is in your spam or junk folder.
    • Or you may contact us at .
  • Copyright © Amerigo Scientific. All rights reserved.